Winners receive the ultimate recognition for innovation that improves the human condition
NEW YORK, Oct. 28, 2022 /PRNewswire/ — The Prix Galien USA Committee honored excellence and innovation in life sciences during the Prix Galien USA Forum and 16th annual Prix Galien Awards Gala last night at the American Museum of Natural History in New York City. The USA Committee, composed of 10 renowned leaders from the biomedical industry and academia, including two Nobel Laureates, honored winners in the following categories: “Best Biotechnology Product,” “Best Pharmaceutical Agent,” “Best Medical Technology,” “Best Digital Health Solution,” “Incubators, Accelerators and Equity,” and “Prix Galien Startup.”
Winners of the Prix Galien Golden Jubilee were also awarded for “Best Biotechnology Product,” “Best Pharmaceutical Product,” “Best Medical Technology,” “Best Orphan/Rare Disease Product,” and “Best Vaccine.” The Golden Jubilee Awards were presented by Sharon Stone, American actress and spokesperson for the American Foundation for AIDS Research since 1995. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize for the life science industry.
The 2022 Prix Galien USA Award Winners
|
Best Biotechnology Product |
Regeneron Pharmaceuticals, Inc. |
Inmazeb™ (atoltivimab, maftivimab, and odesivimab-ebgn) |
|
Best Pharmaceutical Agent |
Amgen Inc. |
LUMAKRAS® |
|
Best Medical Technology |
Cala Health |
Cala… |
